Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, United States; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
Kerstin Ure
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, United States; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
Ying-Wooi Wan
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, United States; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, United States; Howard Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, United States
Alexander J Trostle
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, United States; Department of Pediatrics, Baylor College of Medicine, Houston, United States
Wei Wang
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, United States; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
Haijing Jin
Graduate Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, United States
Joanna Lopez
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, United States; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
Jacinta Lucero
Computational Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, United States
Mark A Durham
Program in Developmental Biology, Baylor College of Medicine, Houston, United States; Medical Scientist Training Program, Baylor College of Medicine, Houston, United States
Rosa Castanon
Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, United States
Joseph R Nery
Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, United States
Zhandong Liu
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, United States; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States; Graduate Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, United States
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States; Program in Developmental Biology, Baylor College of Medicine, Houston, United States; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, United States; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, United States; Department Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States
Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, United States; Howard Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, United States
M Margarita Behrens
Computational Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, United States; Department of Psychiatry, University of California San Diego, La Jolla, United States
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, United States; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States; Department of Pediatrics, Baylor College of Medicine, Houston, United States; Program in Developmental Biology, Baylor College of Medicine, Houston, United States; Department of Neuroscience, Baylor College of Medicine, Houston, United States; Howard Hughes Medical Institute, Baylor College of Medicine, Houston, United States
Methylated cytosine is an effector of epigenetic gene regulation. In the brain, Dnmt3a is the sole ‘writer’ of atypical non-CpG methylation (mCH), and MeCP2 is the only known ‘reader’ for mCH. We asked if MeCP2 is the sole reader for Dnmt3a dependent methylation by comparing mice lacking either protein in GABAergic inhibitory neurons. Loss of either protein causes overlapping and distinct features from the behavioral to molecular level. Loss of Dnmt3a causes global loss of mCH and a subset of mCG sites resulting in more widespread transcriptional alterations and severe neurological dysfunction than MeCP2 loss. These data suggest that MeCP2 is responsible for reading only part of the Dnmt3a dependent methylation in the brain. Importantly, the impact of MeCP2 on genes differentially expressed in both models shows a strong dependence on mCH, but not Dnmt3a dependent mCG, consistent with mCH playing a central role in the pathogenesis of Rett Syndrome.